Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), bought 83,080 shares at $8.16 ($657K) on 2019-06-03, disclosed to the SEC on 2019-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.16 | 15,770 | $129K | 19.6% |
| 2 | $8.16 | 15,770 | $129K | 19.6% |
| 3 | $7.75 | 25,770 | $200K | 30.4% |
| 4 | $7.75 | 25,770 | $200K | 30.4% |
| Total | $7.91 avg | 83,080 | $657K | 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |